| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -0.37% | -4.61% | +4.24% | +4.24% | — |
| 14d | 1 | +0.00% | +3.35% | -3.11% | +6.46% | +6.46% | — |
| 30d | 1 | +100.00% | -26.57% | -3.74% | -22.82% | -22.82% | — |
| 60d | 1 | +100.00% | -28.26% | -6.14% | -22.12% | -22.12% | — |
| 90d | 1 | +0.00% | +4.88% | +4.06% | +0.82% | +0.82% | — |
| 180d | 1 | +100.00% | -12.16% | +9.79% | -21.96% | -21.96% | — |
| 1y | 1 | +100.00% | -55.91% | +31.20% | -87.12% | -87.12% | — |
| 2y | 1 | +100.00% | -23.42% | +16.45% | -39.87% | -39.87% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 25,000 | $6.88 | $172.0K | 68,602 | Aug 31, 2020 | Sep 1, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 25,000 | — | — | 97,961 | Aug 31, 2020 | Sep 1, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 25,000 | $30.00 | $750.0K | 43,602 | Aug 31, 2020 | Sep 1, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASE Chief Commercial Officer | 14,534 | $6.88 | $100.0K | 43,602 | Aug 11, 2020 | Aug 13, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | SALE Chief Commercial Officer | 14,534 | — | — | 122,961 | Aug 11, 2020 | Aug 13, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 30, 2020 | Jul 2, 2020 ↗ | View → |
| RYTM RHYTHM PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |